Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries

A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries,  catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fundSeveral rapid, point-of-care antigen tests are being assessed by…

News

OFFICIAL SOURCE DESK

Original publisher: World Health Organization. PRESS01 links readers to the complete originating publication.

View original source →

Official-source notice

A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries,  catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fundSeveral rapid, point-of-care antigen tests are being assessed by…

This update was issued by World Health Organization. PRESS01 has not reproduced the complete source publication. Consult the linked original for supporting documents, full context, image credits and later amendments.

PRESS01 transparency note
This item is an attributed source notice. Editorial context, corrections and significant later developments may be added to this page.